Quantcast

Latest Sinovac Biotech Stories

2014-05-21 08:28:31

DALLAS, May 21, 2014 /PRNewswire/ -- ReportsnReports.com offers "Vaccines: The End of Illness" and other vaccine market research reports focusing on vaccine technology, HIV, China's animal vaccine industry and cancer vaccine partnering terms and agreements. Vaccines: The End of Illness 2014 market research report focuses on the most recent vaccine research [http://www.reportsnreports.com/reports/286914-vaccines-the-end-of-illness.html ], emphasizing their reputation as...

2014-05-12 08:30:24

BEIJING, May 12, 2014 /PRNewswire/ -- Sinovac Biotech Ltd. (Nasdaq: SVA), a leading provider of biopharmaceutical products in China, today announced that it will release its unaudited financial results for the first quarter ended March 31, 2014, after market closes on Wednesday, May 21, 2014 EDT. The Company will host a conference call prior to the market opening on Thursday, May 22, 2014, at 8:00 a.m. EDT (Thursday, May 22, 2014 at 8:00 p.m. China Standard Time) to review the...

2014-04-28 08:30:45

Collaborating with World Health Organization and Intravacc to Develop sIPV in line with mission to secure a lasting polio-free world, free of all paralytic polio disease BEIJING, April 28, 2014 /PRNewswire/ -- Sinovac Biotech Ltd. (Nasdaq: SVA), a leading provider of biopharmaceutical products in China that focuses on the research, development, manufacturing and commercialization of vaccines, announced today that it has entered into a license agreement with Intravacc (Institute for...

2014-04-24 08:32:33

RMB 60 Million Free Grant for Construction of Dedicated Production Facility BEIJING, April 24, 2014 /PRNewswire/ -- Sinovac Biotech Ltd. (NASDAQ: SVA), a leading China-based vaccine manufacturer, announced today that it has received notification that a RMB 60 million free government grant has been approved by China's Ministry of Finance, National Development and Reform Commission, Ministry of Industry and Information Technology, and National Health and Family Planning Commission for...

2014-04-16 08:34:34

BEIJING, April 16, 2014 /PRNewswire/ -- Sinovac Biotech Ltd. (Nasdaq: SVA), a leading provider of biopharmaceutical products in China that focuses on the research, development, manufacturing and commercialization of vaccines, announced today that it has filed its 2013 Annual Report on Form 20-F with the U.S. Securities and Exchange Commission for the year ended December 31, 2013 on April 16, 2014. The Annual Report on Form 20-F is now available on the Company's website under SEC...

2014-03-25 08:23:39

DUBLIN, Mar. 25, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/n86mjg/china_human ) has announced the addition of the "Concise Analysis of the International Human Vaccine Industry" report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769) In the wake of China's economic growth and enhanced disease prevention awareness, Chinese human vaccine market has been expanding. In 2012, Chinese human vaccine market valued RMB10.5...

2014-03-20 16:26:59

DUBLIN, March 20, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/n8dfqv/china_influenza) has announced the addition of the "China Influenza Vaccine Industry Report 2014" [http://www.researchandmarkets.com/research/n8dfqv/china_influenza ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) The China Influenza Vaccine Industry Report 2014 is a professional and in-depth study on the...

2014-03-19 20:21:13

- Conference call scheduled for Thursday, March 20, 2014 at 8:00 AM EDT - BEIJING, March 19, 2014 /PRNewswire/ -- Sinovac Biotech Ltd. (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, announced today its unaudited fourth quarter and full year financial results for the period ended December 31, 2013. Unaudited Fourth Quarter 2013 Financial Highlights (period-over-period comparisons to fourth quarter 2012) -- Quarterly sales increased by 17.1% to $22.9 million...

2014-03-12 08:29:43

BEIJING, March 12, 2014 /PRNewswire/ -- Sinovac Biotech Ltd. (Nasdaq: SVA), a leading provider of biopharmaceutical products in China, today announced that it will release its unaudited financial results for the fourth quarter and whole year ended December 31, 2013, after market closes on Wednesday, March 19, 2014 EDT. The Company will host a conference call prior to the market opening on Thursday, March 20, 2014, at 8:00 a.m. EDT (Thursday, March 20, 2014 at 8:00 p.m. China Standard...

2014-02-26 16:26:54

Study shows vaccine provides protection against EV71-associated hand, foot and mouth disease in infants and young children BEIJING, Feb. 26, 2014 /PRNewswire/ -- Sinovac Biotech Ltd. (Nasdaq: SVA), a leading provider of biopharmaceutical products in China, announced today that Phase III clinical trial results for its proprietary Enterovirus 71 ("EV71") vaccine have been published online in the February 27(th) issue of The New England Journal of Medicine ("NEJM"). The clinical results...


Word of the Day
jument
  • A beast of burden; also, a beast in general.
'Jument' ultimately comes from the Latin 'jugum,' yoke.
Related